Biomet Offers $280M For Johnson & Johnson Trauma Biz

Law360, New York (April 3, 2012, 2:35 PM EDT) -- Medical device maker Biomet Inc. offered Tuesday to scoop up Johnson & Johnson's global trauma business for $280 million, a divestment that could help the health care giant assuage European Union antitrust regulators' concerns over J&J's proposed $21.3 billion merger with orthopedic device maker Synthes Inc.

The binding offer, which expires June 1, proposes an all-cash deal to buy up DePuy Orthopaedics Inc., a worldwide business based in Massachusetts and Indiana that, like Biomet, makes devices for hip, knee and trauma surgeries, as well as bone...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.